- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7209
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Erratum to: miRNAs: micro-managers of anticancer combination therapies ; day:19 ; month:7 ; year:2017 ; pages:1
Angiogenesis ; (19.7.2017), 1
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Beijnum, Judy R. van
- Beteiligte Personen und Organisationen
-
Giovannetti, Elisa
Poel, Dennis
Nowak-Sliwinska, Patrycja
Griffioen, Arjan W.
SpringerLink (Online service)
- DOI
-
10.1007/s10456-017-9564-7
- URN
-
urn:nbn:de:1111-201708231922
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Beijnum, Judy R. van
- Giovannetti, Elisa
- Poel, Dennis
- Nowak-Sliwinska, Patrycja
- Griffioen, Arjan W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Clinical development of targeted and immune based anti-cancer therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Association between the antioxidant properties of SESN proteins and anti-cancer therapies
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Clinical development of targeted and immune based anti-cancer therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Association between the antioxidant properties of SESN proteins and anti-cancer therapies
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Clinical development of targeted and immune based anti-cancer therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Association between the antioxidant properties of SESN proteins and anti-cancer therapies
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?